A variant 2677A allele of the gene affects fexofenadine disposition
Data up to Jan 2025
Total Citations Per Year
Abstract
References (41)
ABC Transporters: From Microorganisms to Man
1992 • 3,956 citations
Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.
1987 • 2,788 citations
Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo
2000 • 2,358 citations
Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.
1995 • 1,109 citations
Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues.
1990 • 1,063 citations
The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.
1998 • 1,058 citations
Identification of functionally variant MDR1 alleles among European Americans and African Americans
2001 • 1,000 citations
The superfamily of organic anion transporting polypeptides
2002 • 859 citations
Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects
2001 • 757 citations
Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine*
1997 • 675 citations
Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study
2002 • 670 citations
Fruit juices inhibit organic anion transporting polypeptide–mediated drug uptake to decrease the oral availability of fexofenadine
2002 • 604 citations
OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine.
1999 • 585 citations
Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene.
2001 • 538 citations
Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16.
1988 • 443 citations
The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells
2001 • 377 citations
MDR1 genotype-related pharmacokinetics of digoxin after single oral administration in healthy Japanese subjects.
2001 • 319 citations
Pharmacogenetics goes genomic
2003 • 318 citations
Modulation of steady‐state kinetics of digoxin by haplotypes of the P‐glycoprotein MDR1 gene
2002 • 307 citations
Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery
1997 • 283 citations
Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations
2002 • 281 citations
Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P‐glycoprotein
2002 • 268 citations
Effect of the mutation (C3435T) at exon 26 of the MDR1 gene on expression level of MDR1 messenger ribonucleic acid in duodenal enterocytes of healthy Japanese subjects
2002 • 266 citations
Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms.
1995 • 254 citations
MDR1 gene polymorphisms and disposition of the P‐glycoprotein substrate fexofenadine
2002 • 250 citations
Genetic polymorphisms in MDR1 and CYP3A4 genes in Asians and the influence of MDR1 haplotypes on cyclosporin disposition in heart transplant recipients
2003 • 248 citations
The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humans
2002 • 247 citations
The Mucosa of the Small Intestine
2002 • 230 citations
The drug efflux–metabolism alliance: biochemical aspects
2001 • 230 citations
Pharmacogenetics of MDR1 and its impact on the pharmacokinetics and pharmacodynamics of drugs
2003 • 226 citations
The effects of the human MDR1 genotype on the expression of duodenal P‐glycoprotein and disposition of the probe drug talinolol
2002 • 201 citations
Digoxin pharmacokinetics and MDR1 genetic polymorphisms
2003 • 169 citations
Genetic Polymorphism in MDR-1: A Tool for Examining Allelic Expression in Normal Cells, Unselected and Drug-Selected Cell Lines, and Human Tumors
1998 • 157 citations
MDR1 genotypes do not influence the absorption of a single oral dose of 1 mg digoxin in healthy white males
2002 • 153 citations
Significant genetic linkage of MDR1 polymorphisms at positions 3435 and 2677: functional relevance to pharmacokinetics of digoxin.
2002 • 129 citations
Pharmacokinetic and prognostic significance of intestinal MDR1 expression in recipients of living‐donor liver transplantation
2001 • 125 citations
Human MDR1 polymorphism: G2677T/A and C3435T have no effect on MDR1 transport activities
2003 • 121 citations
Pharmacogenomics of organic anion-transporting polypeptides (OATP)
2002 • 112 citations
Effects of grapefruit juice and orange juice on the intestinal efflux of P-glycoprotein substrates.
2002 • 104 citations
Active intestinal secretion of the fluoroquinolone antibacterials ciprofloxacin, norfloxacin and pefloxacin; a common secretory pathway?
1994 • 94 citations
Determination of terfenadine and terfenadine acid metabolite in plasma using solid-phase extraction and high-performance liquid chromatography with fluorescence detection
1991 • 72 citations